Skip to content
Riskpilot
← Back to search
Sign in
Get full access
GXP PHARMAID ApS
APS
Active
CVR 29615861
Korsager Allé 9, 2700
Brønshøj
Engineering activities and related technical consultancy
·
NACE 7112
Est. 2006 · 20 years old
1 employees
www.cgxp.eu
Monitor
Share
Denmark
/
Companies
/
Engineering activities and related technical consultancy
/
GXP PHARMAID ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
1M
2M
3M
3M
3M
2020
0M
2021
0M
2022
1M
2023
1M
2024
EBITDA
DKK millions
1M
1M
0M
-1M
-1M
1M
2020
-1M
-200%
2021
0M
+100%
2022
1M
+100%
2023
0M
-100%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
2.799
363
350
1.192
1.341
Staff expenses
-1.559
-990
-735
-517
-844
EBITDA
1.240
-627
-385
675
497
Depreciation & amort.
-17
-15
-10
-0
-0
EBIT
1.224
-642
-395
675
497
Net financials
-32
-2
-16
-16
-159
Profit before tax
1.192
-644
-410
659
337
Tax
231
-140
-86
145
121
Net profit
960
-504
-325
513
217
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
2.984
1.031
1.246
1.682
1.802
Equity
1.695
691
367
880
1.096
Long-term debt
0
0
0
0
0
Short-term debt
1.289
340
880
803
706
Total debt
1.289
340
880
803
706
Financial ratios
5-year trend
EBITDA margin (of gross profit)
37.1%
This company
2020
2024
Equity ratio
60.8%
This company
38.2%
Market median
+59% vs market
2020
2024
Return on equity
19.8%
This company
18.4%
Market median
+8% vs market
2020
2024
Net profit margin (of gross profit)
16.1%
This company
2020
2024
Asset turnover (of gross profit)
0.74×
This company
2020
2024
Debt / equity
0.64×
This company
0.62×
Market median
+3% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on GXP PHARMAID ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
